ENTITY
Peptidream Inc

Peptidream Inc (4587 JP)

28
Analysis
Health CareJapan
PeptiDream Inc. is a biopharmaceutical company that researches and develops peptide therapeutics to improve the life of patients.
more
17 Apr 2017 06:55

The Week That Was in NorthAsia@Smartkarma: Toshiba, Peptidream, and Missiles

It's been a full week for coverage of North Asia on Smartkarma. 30-odd insights on Japan and a dozen on Korea.ToshibaThe big theme of the week, and...

Logo
Mio Kato
357 Views
Share
bullishMedrx Co Ltd
16 Apr 2017 18:50

Medrx - Japan Biotech Microcap in Potential Big Licensing Deal

Although the Japanese drug industry suffers from a lack of scale, where it is good is in applying manufacturing techniques to develop not just...

bullishPeptidream Inc
11 Apr 2017 21:53

PeptiDream: J&J Latest Drug Major to Tie Up

On the surface, Peptidream's (4587 JP) deal with Johnson & Johnson's (JNJ US) Janssen unit looks no different from the deals they have cut with...

10 Apr 2017 16:15

Sosei & Kyowa Hakko Kirin: Positive News on GPCR Drugs

Kyowa Hakko Kirin's (4151 JP) announcement that “moga” – mogamulizumab (KW-0761) – has met its primary endpoint (PFS) in Phase III trials for...

06 Aug 2016 18:07

Death Rattle for Defensives?

While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good...

x